Latest South Africa News

Cobre Limited has announced a fully underwritten loyalty options offer to raise approximately $1.18 million, offering eligible shareholders one new option for every three shares held at $0.008 each. The new options carry an exercise price of $0.066 and expire in November 2028.

ASPI Isotopes Inc. has proposed a scheme to acquire all Renergen shares at a 41.3% premium, aiming to create a global critical materials powerhouse. The deal, subject to shareholder and regulatory approval, will delist Renergen from multiple exchanges.

Kinetiko Energy has completed a $2.2 million placement, supported by directors and major shareholders, to advance its gas exploration and production testing in South Africa’s Mpumalanga Province. Initial production test results are expected in July 2025.

Southern Palladium has raised A$8 million through a strategic placement to accelerate its Definitive Feasibility Study and staged mine development at the Bengwenyama PGM project, backed by a major cornerstone investor.

Close the Loop Limited reports steady revenue but a sharp 50% drop in EBITDA for the second half of FY25, driven by operational challenges in North America. A leadership change and strategic shifts aim to stabilise growth.

Theta Gold Mines has landed a US$35 million loan from South Africa’s Industrial Development Corporation, marking a key funding milestone for its TGME Underground Gold Mine Project.

European Lithium Ltd and Critical Metals Corp have updated the Tanbreez Rare Earth Project scoping study, incorporating feldspar and arfvedsonite alongside eudialyte, underpinning a robust $2.4–3.0 billion NPV and a 162% IRR over a 19-year mine life.

TerraCom Limited has reached a significant settlement with ASIC to resolve whistleblower-related civil proceedings, agreeing to pay $8.5 million pending Federal Court approval.

South Africa’s Minister of Mineral Resources has upheld Renergen’s helium extraction rights at the Virginia Gas Project, rejecting an appeal from Springbok Solar and securing the company’s production future.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

Chilwa Minerals has reported impressive high-grade heavy mineral sand assay results from its Mpyupyu Dune deposit in Malawi, confirming thicker and richer mineralisation than previously estimated. These findings pave the way for an upcoming scoping study and resource upgrades.